Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

patient care perspectives

Present Capabilities and Future Directions of Molecular Profiling in Chronic Lymphocytic Leukemia

Present Capabilities and Future Directions of Molecular Profiling in Chronic Lymphocytic Leukemia

patient care perspectives
By John C. Byrd, MD

Prognostic Indicators in Early-Stage HER2+ Breast Cancer

Prognostic Indicators in Early-Stage HER2+ Breast Cancer

patient care perspectives
By Joseph A. Sparano, MD, FACP, FASCO

Waning Control of Diarrhea 3 to 4 Weeks After Long-Acting Somatostatin Analogue Injection

Waning Control of Diarrhea 3 to 4 Weeks After Long-Acting Somatostatin Analogue Injection

patient care perspectives
By Jonathan R. Strosberg, MD

Current Approaches and Outcomes in Complement-Mediated Kidney Diseases: A Focus on Complement 3 Glomerulopathy

Current Approaches and Outcomes in Complement-Mediated Kidney Diseases: A Focus on Complement 3 Glomerulopathy

patient care perspectives
By Carla M. Nester, MD, MSA, FASN

Optimal Practices for Active Surveillance in Chronic Lymphocytic Leukemia

Optimal Practices for Active Surveillance in Chronic Lymphocytic Leukemia

patient care perspectives

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?